Skip to main content
logo
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
10.57
+0.32 (3.12%)
Nov 6, 2026, 4:00 PM EST - Market closed

Monte Rosa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9021,021426283368950
Market Cap Growth
18.61%139.48%50.74%-23.21%-61.22%-
Enterprise Value
360670228151142583
Last Close Price
10.5715.686.945.657.6120.42

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
12.828.265.64---
PB Ratio
1.824.381.911.581.362.73
P/TBV Ratio
1.824.381.911.581.362.73
P/FCF Ratio
--11.22---
P/OCF Ratio
--10.15---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.125.423.01---
EV/FCF Ratio
--6.00---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.170.190.260.17-
Debt / FCF Ratio
--1.12---
Net Debt / Equity Ratio
-1.09-1.45-1.48-1.04-0.79-1.00
Net Debt / EBITDA Ratio
3.807.374.511.361.994.89
Net Debt / FCF Ratio
3.1112.29-8.672.972.055.01
Asset Turnover
0.120.280.20---
Quick Ratio
10.246.052.375.0010.5820.80
Current Ratio
10.326.122.405.0710.7920.96
Return on Equity (ROE)
-35.30%-16.94%-36.15%-60.07%-35.06%-40.35%
Return on Assets (ROA)
-16.29%-7.64%-13.66%-27.72%-19.82%-21.92%
Return on Capital Employed (ROCE)
-23.70%-14.10%-28.80%-55.70%-35.50%-20.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-12.75%-3.78%-17.05%-47.85%-29.46%-7.79%
FCF Yield
-19.34%-2.69%8.91%-22.22%-28.61%-7.28%
Buyback Yield / Dilution
-17.46%-12.39%-43.80%-8.83%-88.91%-1548.09%
SEC Filings: 10-K · 10-Q